Targeting Lymphomas Using Non-Engineered, Multi-Antigen-Specific T Cells

被引：0
|
作者：
Carrum, George [1 ,2 ]
Lulla, Premal [1 ,2 ]
Tzannou, Ifigeneia [3 ]
Watanabe, Ayumi [3 ]
Kuvalekar, Manik [3 ]
Bilgi, Mrinalini [3 ]
Wang, Tao [4 ]
Kamble, Rammurti T. [1 ,2 ]
Ramos, Carlos A. [3 ]
Rouce, Rayne Helen [3 ]
Grilley, Bambi [3 ]
Gee, Adrian P. [3 ]
Brenner, Malcolm K. [5 ,6 ]
Heslop, Helen E. [5 ]
Rooney, Cliona M. [3 ]
Vera, Juan F. [3 ]
Leen, Ann M. [5 ,6 ]
机构：
[1] Houston Methodist Hosp, Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
[2] Texas Childrens Hosp, Houston, TX 77030 USA
[3] Houston Methodist Hosp, Texas Childrens Hosp, Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
[4] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA
[5] Texas Childrens Hosp, Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
[6] Houston Methodist Hosp, Texas Childrens Hosp, Houston, TX 77030 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
24
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Targeting Lymphomas Using Non-Engineered, Multi-Antigen Specific T Cells
    Carrum, George
    Lulla, Premal
    Tzannou, Ifigeneia
    Watanabe, Ayumi
    Kuvalekar, Manik
    Bilgi, Mrinalini
    Kamble, Rammurti
    Ramos, Carlos A.
    Rouce, Rayne
    Grilley, Bambi J.
    Gee, Adrian P.
    Brenner, Malcolm K.
    Heslop, Helen E.
    Rooney, Cliona M.
    Vera, Juan F.
    Leen, Ann M.
    BLOOD, 2018, 132
  • [2] Multi-antigen-specific T cell therapy for multiple myeloma
    Sarah Crunkhorn
    Nature Reviews Drug Discovery, 2020, 19 (9) : 588 - 588
  • [3] Non-engineered T cells with specific anticancer effects in KRAS-mutated colorectal cancer
    Lim, Sunki
    Gho, Yujeong
    Kim, Seoyoung
    Kim, Min Ki
    Park, Jong Seob
    Lee, Wang Jun
    Lee, Young-Kwan
    Moon, Hyoun Jong
    CANCER RESEARCH, 2023, 83 (07)
  • [4] The specific cytotoxicities of chimeric antigen receptor-engineered T cells on different lymphomas
    张蕊
    China Medical Abstracts(Internal Medicine), 2017, 34 (04) : 230 - 230
  • [5] Targeting antigen-specific T cells by genetically engineered antigen presenting cells - A strategy for specific immunotherapy of autoimmune disease
    Wu, JM
    Wu, B
    Guarnieri, F
    August, JT
    Drachman, DB
    JOURNAL OF NEUROIMMUNOLOGY, 2000, 106 (1-2) : 145 - 153
  • [6] Targeting AML with Multi-Antigen Specific T Cells Engineered to Express a CAR Specific for SSX2 Peptide 41-49
    Pezzella, Gloria
    Achour, Achouak
    Yvon, Eric S.
    Bollard, Catherine M.
    Toner, Keri
    MOLECULAR THERAPY, 2024, 32 (04) : 77 - 78
  • [7] Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
    Nina Lamers-Kok
    Denise Panella
    Anna-Maria Georgoudaki
    Haiping Liu
    Didem Özkazanc
    Lucia Kučerová
    Adil Doganay Duru
    Jan Spanholtz
    Monica Raimo
    Journal of Hematology & Oncology, 15
  • [8] Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
    Lamers-Kok, Nina
    Panella, Denise
    Georgoudaki, Anna-Maria
    Liu, Haiping
    Ozkazanc, Didem
    Kucerova, Lucia
    Duru, Adil Doganay
    Spanholtz, Jan
    Raimo, Monica
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [9] Targeting Antigen-Specific B Cells Using Antigen-Expressing Transduced Regulatory T Cells
    Zhang, Ai-Hong
    Yoon, Jeongheon
    Kim, Yong Chan
    Scott, David W.
    JOURNAL OF IMMUNOLOGY, 2018, 201 (05): : 1434 - 1441
  • [10] Preclinical targeting of human T-cell malignancies using CD4-specific chimeric antigen receptor (CAR)-engineered T cells
    Pinz, K.
    Liu, H.
    Golightly, M.
    Jares, A.
    Lan, F.
    Zieve, G. W.
    Hagag, N.
    Schuster, M.
    Firor, A. E.
    Jiang, X.
    Ma, Y.
    LEUKEMIA, 2016, 30 (03) : 701 - 707
12345